Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared BPC-157 for therapeutic use in humans or animals
Formulated for human consumption
The BPC-157 dosage calculator can help determine appropriate amounts based on individual factors
Journal of Clinical Endocrinology and Metabolism, 106(2), 388-396
It is given by subcutaneous injection, sometimes near the area of concern depending on the clinical goal
2.4 mg once weekly is the highest cagrilintide dose used in clinical development, including the CagriSema program
US$ 20.36
US$ 25.73
US$ 20.50
US$ 29.03
US$ 28.90
US$ 20.91
US$ 28.99
